目的: 分析典型检验类项目价格治理现状,为进一步规范医疗服务价格治理工作提供参考。方法: 以第一批国家价格治理的4个检验类项目为研究对象,梳理现行检验类价格项目存在的问题,以描述性统计分析方法对比治理前后价格水平的动态演变以及区域间项目间比价关系。结果: 各地检验类价格项目存在异质性;规范治理前价格水平的区域差异特征明显,政策实施后检验类项目价格体系呈现价格水平整体下行与省际价差空间收窄的双重趋势;检测方法学比价存在整体优化与局部失衡。结论: 价格规范治理基本实现区域间价格相对均衡的目标,但同类项目方法学比价关系优化还有提升空间。建议构建全国统一的检验类价格项目标准体系和立项指南,建立技术劳务价值导向的价格优化机制,建立基于临床价值的同类项目比价校准机制。
Abstract
Objective: The paper analyzes the current status of price governance for typical laboratory test items and provides references for the standardization of medical service price governance. Methods: Taking the four laboratory test items in the first batch of national price governance as the research objects, this paper analyzes the problems of current laboratory test items, uses descriptive statistical analysis methods to compare the dynamic evolution of price levels before and after price governance, and the price relations among regions and items. Results: There is heterogeneity in laboratory test price items in various regions. Before standardized governance, the regional difference of price levels was obvious. After the implementation of the policy, the price system of laboratory test items showed a trend of overall downward price levels and narrowing of inter-provincial price differences. The price comparison of detection methodologies shows overall optimization but regional imbalance. Conclusion: The standardization and governance of price have basically achieved the goal of relatively balanced prices among regions, but there is still room for improvement in the optimization of price relations of methodologies for similar items. It is suggested to establish a unified national standard system and project initiation guidelines for price of laboratory test items, a price optimization mechanism guided by the value of technology and labor services, and a comparison and calibration mechanism for similar items based on clinical value.
关键词
检验类项目 /
医疗服务价格 /
价格项目 /
价格规范治理 /
比价关系
Key words
laboratory test items /
medical service price /
price items /
price standardization and governance /
price relations
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] TANG W, XIE J, LU Y, et al.Effects on the medical revenue of comprehensive pricing reform in Chinese urban public hospitals after removing drug markups: case of Nanjing[J].Journal of medical economics, 2018, 21(4): 326-339.
[2] LIU M, JIA M, LIN Q, et al.Effects of Chinese medical pricing reform on the structure of hospital revenue and healthcare expenditure in county hospital: an interrupted time series analysis[J].BMC health service research, 2021, 21(1):385.
[3] ZHU D, SHI X, NICHOLAS S, et al.Impact of China's healthcare price reforms on traditional Chinese medicine public hospitals in Beijing: an interrupted time-series study[J].BMJ Open, 2019, 9(8): e029646.
[4] 魏添添,祝贺,刘晓云.北京市公立医院综合改革对医疗机构技术劳务收入的影响分析[J].中国卫生政策研究,2021,14(4):1-10.
[5] 郑大喜.检验类医疗服务项目价格政策解读、实施难点与突破[J].现代医院管理,2023,21(05):42-46.
[6] 张杰,方晓蕾,王俊,等.血栓弹力图指导输血在老年骨科大手术患者中的应用[J].海南医学,2019,30(21):2775-2778.
[7] 中华医学会糖尿病学分会.中国血糖监测临床应用指南(2015年版)[J].中华糖尿病杂志,2015,7(10):603-613.
[8] 张文娟,於江泉,邵俊,等.早期血浆N末端B型钠尿肽前体测定对于顽固性感染性休克患者预后的评估[J].临床医药文献电子杂志,2016,3(16):3226.
[9] 尹代江,李凌珊,赵成元,等.血浆B型钠尿肽测定在慢性心力衰竭患者诊断及预后中的临床价值[J].现代医药卫生,2015,31(01):21-23.
[10] 王瑶莹,牛亚冬,付晓丽,等.医学检验项目定价“技耗分离”:内涵、难点和路径[J].中国卫生经济,2025,44(01):47-49.
[11] 王美凤,王海银,王力男,等.上海市医疗服务价格调整后公立医院医疗收支构成变动分析[J].中国卫生经济,2019,38(03):23-26.
[12] 邵雪丽,于莎莎,赵要军,等.医学检验项目试剂成本标准资源消耗研究[J].中国医院,2022,26(10):61-63.
[13] 国家医保局,国家卫生健康委,国家发展改革委,等.关于印发《深化医疗服务价格改革试点方案》的通知[EB/OL].(2021-08-31)[2025-03-11].https://www.nhsa.gov.cn/art/2021/8/31/art_37_5896.html.
[14] 江苏省医疗保障局,江苏省卫生健康委员会.关于做好无创产前基因检测服务带量采购中选结果执行工作的通知[EB/OL].(2024-10-28)[2025-03-11].https://ybj.jiangsu.gov.cn/art/2024/10/28/art_91138_11406390.html.
[15] 蒋婷,王朝辉,蒋昌松,等.典型医疗服务项目价格水平的国际比较[J].卫生经济研究,2024,41(06):68-71+77.
[16] 蒋昌松,蒋婷,王朝辉,等.通用型医疗服务价格项目比价关系研究——以诊察费为例[J].中国医疗保险,2024(03):5-10.
[17] 蒋昌松,吕兰婷,蒋婷,等.医疗服务价格改革调价总量的测算方法及实证分析[J].中华医院管理杂志,2023,39(7):475-479.
基金
国家医疗保障局课题“高值医用耗材价格梳理和大型医疗设备检查价格治理”（ZCS - KTXY-2024-033）
